What You Need To Know About UiPath Inc (PATH)

UiPath Inc (NYSE:PATH) finished Thursday with an addition of $0.48 to close at $16.77, an upside of 2.95 percent. An average of 5,653,300 shares of common stock have been traded in the last five days. There was a gain of $0.45 in the past week, and it reached a new high 15 times over the past 12 months. The last 20 days have seen an average of 9,270,760 shares traded, while the 50-day average volume stands at 7,286,284.

PATH stock has increased by 7.23% in the last month. The company shares reached their 1-month lowest point of $14.94 on 08/29/23. With the stock rallying to its 52-week high on 06/07/23, shares of the company touched a low of $10.40 and a high of $19.94 in 52 weeks. It has reached a new high 13 times so far this year and achieved 31.94% or $4.06 in price. In spite of this, the price is down -15.90% from the 52-week high.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

Insider Transactions

PATH stock investors should be aware that UiPath Inc (PATH) stock had its last reported insider trading activity 7 days ago on Sep 22. In this transaction, the insider spent $1,638,080. Chief Financial Officer, Gupta Ashim, disposed of 40,000 shares at a price of $17.38 on Sep 15. The insider now owns more than $695,272 worth of shares. Prior to that, Chief Financial Officer Gupta Ashim went on to Sale 12,000 shares at $17.38 each on Sep 15. An amount of $208,595 was transacted.

Valuation Metrics

UiPath Inc (PATH) stock’s beta is 0.61. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 8.28, the price-to-book (PB) ratio at 4.79, and the price-to-cash flow ratio at 53.91.

Financial Health

The quick ratio of UiPath Inc for the recent quarter was 4.33, and the current ratio was 4.33, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.03 and a total debt to equity ratio of 0.03 for the recent quarter. UiPath Inc’s EBITDA margin is -27.81%, while its operating margin for the same period stands at -19.34%. Its gross profit as reported stood at $878.53 million compared to revenue of $1.06 billion.

Earnings Surprise

In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$60.36 million in the quarter, while revenues of -$31.9 million were shrunk -99.44%. Shareholders own equity worth $566.74 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at UiPath Inc (PATH) price momentum. RSI 9-day as of the close on 28 September was 51.30%, suggesting the stock is Neutral, with historical volatility in this time frame at 34.36%.

As of today, PATH’s price is $16.28 +2.76% or $0.45 from its 5-day moving average. PATH is currently trading +7.43% higher than its 20-day SMA and +30.30% higher than its 100-day SMA. However, the stock’s current price level is -9.30% below the SMA50 and +29.50% above the SMA200.

The stochastic %K and %D were 14.52% and 10.22%, respectively, and the average true range (ATR) was 0.71. With the 14-day stochastic at 27.95% and the average true range at 0.72, the RSI (14) stands at 51.18%. The stock has reached -0.28 on the 9-day MACD Oscillator while the 14-day reading was at -0.89.

Analyst Ratings

Wells Fargo downgraded UiPath Inc (NYSE: PATH) to a an Equal weight rating in its most recent analyst report. Previously, the stock was rated as an Overweight. The consensus rating for UiPath Inc (PATH) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell PATH, while 12 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 8 others rate it as a “buy”.

What is PATH’s price target for the next 12 months?

Analysts predict a range of price targets between $16.00 and $25.00, with a median target of $19.00. Taking a look at these predictions, the average price target given by analysts for UiPath Inc (PATH) stock is $19.69.

Most Popular

Related Posts